APA (7th ed.) Citation

DN, W., BW, S., ND, S., D, M., M, O., D, S., . . . MS, W. (2014). Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities. Investigational new drugs, 32(6), 1071. https://doi.org/10.1007/s10637-014-0138-x

Chicago Style (17th ed.) Citation

DN, Waterhouse, et al. "Irinophore C™, a Lipid Nanoparticle Formulation of Irinotecan, Abrogates the Gastrointestinal Effects of Irinotecan in a Rat Model of Clinical Toxicities." Investigational New Drugs 32, no. 6 (2014): 1071. https://doi.org/10.1007/s10637-014-0138-x.

MLA (9th ed.) Citation

DN, Waterhouse, et al. "Irinophore C™, a Lipid Nanoparticle Formulation of Irinotecan, Abrogates the Gastrointestinal Effects of Irinotecan in a Rat Model of Clinical Toxicities." Investigational New Drugs, vol. 32, no. 6, 2014, p. 1071, https://doi.org/10.1007/s10637-014-0138-x.